Search results
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
Benzinga via Yahoo Finance· 4 hours agoTuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and...
GSK boasts win for depemokimab in asthma trials
Clinical Trials Arena via Yahoo Finance· 8 hours agoGSK has announced positive data from two Phase III trials of its asthma candidate depemokimab. The pharma giant announced the drug met primary endpoints...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 8 hours agoJohnson and Johnson (J&J) has announced positive data from the Phase III QUASAR maintenance trial...
Vertex (VRTX) Outperforms Industry on Rapid Pipeline Progress
Zacks via Yahoo Finance· 3 hours agoVertex plans to initiate a pivotal phase III program of suzetrigine in diabetic peripheral...
$41.6M bond issued for phase III of Combined Sewer Overflow project
Providence Business News· 16 hours agoThe bond proceeds will help finance the construction of the Narragansett Bay Commission’s Combined...
NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis
Clinical Trials Arena via Yahoo Finance· 6 days agoPhaseV will analyse NeuroSense’s Phase II ALS trial data, and results from these will inform Phase ...
AstraZeneca’s Phase III Covid-19 antibody trial meets primary endpoints
Clinical Trials Arena via Yahoo Finance· 4 days agoAstraZeneca has announced that the Phase III SUPERNOVA clinical trial of its sipavibart (formerly...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 9 hours agoRemeGen Completes Patient Enrollment in Two Phase III Clinical Trials Using Telitacicept for Treatment of IgA Nephropathy and Primary Sjögren's Syndrome ...
89bio begins Phase III trial of treatment for steatohepatitis with cirrhosis
Clinical Trials Arena via Yahoo Finance· 6 days agoUS-based biopharmaceutical company 89bio has begun the Phase III ENLIGHTEN-Cirrhosis clinical trial of pegozafermin for treating metabolic dysfunction-associated ...
Bayer’s non-hormonal therapy reduces hot flashes in Phase III trials
Clinical Trials Arena via Yahoo Finance· 4 days agoBayer’s non-hormonal therapy elinzanetant met primary and secondary endpoints in two pivotal Phase ...
